In the in vivo-based approach, the levels of CHD4 protein expression were evaluated in 172 pairs of cancer tissue samples, and adjacent normal mucosa from patients with rectal cancer, who are receiving neo-adjuvant CCRT, followed by surgery. Here, CHD4 is linked to cancer.